"Designing Growth Strategies is in our DNA"

Antipsychotic Drugs Market Size, Share & COVID-19 Impact Analysis, By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Others), By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI101390

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Psychiatric Disorders, By Key Countries/Regions, 2020
    2. Analysis of the Cost and Burden of Mental Health Disorders
    3. Pipeline Analysis
    4. Overview of Current Advances in R&D for Antipsychotic Drugs
    5. Analysis of Antipsychotics in Treatment of Dementia
    6. Analysis: First Generation Antipsychotics vs. Third Generation Antipsychotics
    7. Key Industry Developments
    8. New Product Launches
    9. Impact of COVID-19 on Antipsychotic Drugs Market
  5. Global Antipsychotic Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast– By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Antipsychotic Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
      2. Canada
  7. Europe Antipsychotic Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Antipsychotic Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    3. Market Analysis, Insights and Forecast– By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Antipsychotic Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Antipsychotic Drugs Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast  – By Disease
      1. Schizophrenia  
      2. Bipolar Disorder
      3. Unipolar Depression
      4. Dementia
      5. Others
    3. Market Analysis, Insights and Forecast – By Therapeutic Class
      1. First Generation
      2. Second Generation
      3. Third Generation
    4. Market Analysis, Insights and Forecast  – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Market Analysis, Insights and Forecast  – By Country/ Sub-Region
      1. GCC
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2020)
    2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))
      1. H. Lundbeck A/S
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      2. Otsuka Pharmaceutical Co., Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      3. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      4. Eli Lilly and Company
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      5. ALLERGAN (AbbVie, Inc.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      6. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      7. Dr. Reddy’s Laboratories Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      8. Sumitomo Dainippon Pharma Co., Ltd.
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      9. Alkermes plc
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)
      10. Bristol-Myers Squibb Company
        1. Overview,
        2. Products & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based On Availability)

List of Figures:

Figure 1:  Global Antipsychotic Drugs Market Revenue Breakdown (USD billion, %) by Region, 2020 & 2028

Figure 2:  Global Antipsychotic Drugs Market Value Share (%), by Disease, 2020 & 2028

Figure 3:  Global Antipsychotic Drugs Market Forecast (USD billion), by Schizophrenia, 2017-2028

Figure 4:  Global Antipsychotic Drugs Market Forecast (USD billion), by Bipolar Disorder, 2017-2028

Figure 5:  Global Antipsychotic Drugs Market Forecast (USD billion), by Unipolar Depression, 2017-2028

Figure 6:  Global Antipsychotic Drugs Market Forecast (USD billion), by Dementia, 2017-2028

Figure 7:  Global Antipsychotic Drugs Market Forecast (USD billion), by Others, 2017-2028

Figure 8:  Global Antipsychotic Drugs Market Value Share (%), by Therapeutic Class, 2020 & 2028

Figure 9:  Global Antipsychotic Drugs Market Forecast (USD billion), by First Generation, 2017-2028

Figure 10:  Global Antipsychotic Drugs Market Forecast (USD billion), by Second Generation, 2017-2028

Figure 11:  Global Antipsychotic Drugs Market Forecast (USD billion), by Third Generation, 2017-2028

Figure 12:  Global Antipsychotic Drugs Market Value Share (%), by Distribution Channel, 2020 & 2028

Figure 13:  Global Antipsychotic Drugs Market Forecast (USD billion), by Hospital Pharmacies, 2017-2028

Figure 14:  Global Antipsychotic Drugs Market Forecast (USD billion), by Drug Stores & Retail Pharmacies, 2017-2028

Figure 15:  Global Antipsychotic Drugs Market Forecast (USD billion), by Online Pharmacies, 2017-2028

Figure 16:  Global Antipsychotic Drugs Market Value (USD billion), by Region, 2020 & 2028

Figure 17:  North America Antipsychotic Drugs Market Value (USD billion), by Disease, 2020 & 2028

Figure 18:  North America Antipsychotic Drugs Market Value Share (%), by Disease, 2020

Figure 19:  North America Antipsychotic Drugs Market Value (USD billion), by Therapeutic Class, 2020 & 2028

Figure 20:  North America Antipsychotic Drugs Market Value Share (%), by Therapeutic Class, 2020

Figure 21:  North America Antipsychotic Drugs Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 22:  North America Antipsychotic Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 23:  North America Antipsychotic Drugs Market Value (USD billion), By Country, 2020 & 2028

Figure 24:  North America Antipsychotic Drugs Market Value Share (%), By Country, 2020

Figure 25:  Europe Antipsychotic Drugs Market Value (USD billion), by Disease, 2020 & 2028

Figure 26:  Europe Antipsychotic Drugs Market Value Share (%), by Disease, 2020

Figure 27:  Europe Antipsychotic Drugs Market Value (USD billion), by Therapeutic Class, 2020 & 2028

Figure 28:  Europe Antipsychotic Drugs Market Value Share (%), by Therapeutic Class, 2020

Figure 29:  Europe Antipsychotic Drugs Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 30:  Europe Antipsychotic Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 31:  Europe Antipsychotic Drugs Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 32:  Europe Antipsychotic Drugs Market Value Share (%), By Country/ Sub-region, 2020

Figure 33:  Asia Pacific Antipsychotic Drugs Market Value (USD billion), by Disease, 2020 & 2028

Figure 34:  Asia Pacific Antipsychotic Drugs Market Value Share (%), by Disease, 2020

Figure 35:  Asia Pacific Antipsychotic Drugs Market Value (USD billion), by Therapeutic Class, 2020 & 2028

Figure 36:  Asia Pacific Antipsychotic Drugs Market Value Share (%), by Therapeutic Class, 2020

Figure 37:  Asia Pacific Antipsychotic Drugs Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 38:  Asia Pacific Antipsychotic Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 39:  Asia Pacific Antipsychotic Drugs Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 40:  Asia Pacific Antipsychotic Drugs Market Value Share (%), By Country/ Sub-region, 2020

Figure 41:  Latin America Antipsychotic Drugs Market Value (USD billion), by Disease, 2020 & 2028

Figure 42:  Latin America Antipsychotic Drugs Market Value Share (%), by Disease, 2020

Figure 43:  Latin America Antipsychotic Drugs Market Value (USD billion), by Therapeutic Class, 2020 & 2028

Figure 44:  Latin America Antipsychotic Drugs Market Value Share (%), by Therapeutic Class, 2020

Figure 45:  Latin America Antipsychotic Drugs Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 46:  Latin America Antipsychotic Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 47:  Latin America Antipsychotic Drugs Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 48:  Latin America Antipsychotic Drugs Market Value Share (%), By Country/ Sub-region, 2020

Figure 49:  Middle East & Africa Antipsychotic Drugs Market Value (USD billion), by Disease, 2020 & 2028

Figure 50:  Middle East & Africa Antipsychotic Drugs Market Value Share (%), by Disease, 2020

Figure 51:  Middle East & Africa Antipsychotic Drugs Market Value (USD billion), by Therapeutic Class, 2020 & 2028

Figure 52:  Middle East & Africa Antipsychotic Drugs Market Value Share (%), by Therapeutic Class, 2020

Figure 53:  Middle East & Africa Antipsychotic Drugs Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 54:  Middle East & Africa Antipsychotic Drugs Market Value Share (%), by Distribution Channel, 2020

Figure 55:  Middle East & Africa Antipsychotic Drugs Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 56:  Middle East & Africa Antipsychotic Drugs Market Value Share (%), By Country/ Sub-region, 2020

Figure 57:  Global Antipsychotic Drugs Market Share (%), By Company, 2020 

List of Tables:

Table 1:  Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Disease, 2016–2028

Table 2:  Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Therapeutic Class, 2016–2028

Table 3:  Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2016–2028

Table 4:  Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Region, 2017-2028

Table 5:  North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Disease, 2017-2028

Table 6:  North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Therapeutic Class, 2017-2028

Table 7:  North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 8:  North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country, 2017-2028

Table 9:  Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Disease, 2017-2028

Table 10:  Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Therapeutic Class, 2017-2028

Table 11:  Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 12:  Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 13:  Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Disease, 2017-2028

Table 14:  Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Therapeutic Class, 2017-2028

Table 15:  Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 16:  Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 17:  Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Disease, 2017-2028

Table 18:  Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Therapeutic Class, 2017-2028

Table 19:  Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 20:  Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 21:  Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Disease, 2017-2028

Table 22:  Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Therapeutic Class, 2017-2028

Table 23:  Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 24:  Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

 class=
  • Jun, 2021
  • 2020
  • 2017-2019
  • 120

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X